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CORRECTION
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Please note that the x axis labeling in Fig. 6 (D and E) was inadvertently cropped. The html and pdf versions are 
correct. The corrected fi  gure is shown below.
  Figure 6.     Effect of infection on CD4     T  EM   cell differentiation from proliferating T  CM   cell precursors. (A) Schema of memory T cell 
differentiation in RMs (  18  ). (B) The top profi  les show CD4     T cells from one RM with attenuated SIVmac239(    nef) infection (PID 387; pvl  
5,200 copies/ml) and one with progressive SIVmac239 infection (PID 579; pvl  3,800,000 copies/ml), indicating the gating of proliferating 
(Ki-67   )  CD4    memory T cells. The bottom profi  les show the representation of T  CM   cells  (CD28  ;  CCR5      ) versus total T  EM   cells  (including 
CD28   ,  CCR5    transitional  T EM   cells, and CD28      /CCR5 dim   mature  T EM   cells) within the proliferating CD4     memory compartment. (C) The 
fi  gure shows cross-sectional analysis of the fractional representation of total T  EM   cells (as in A) in 10 SIV        RMs, 7 RMs with early plateau-
phase SIVmac239 infection (PID 105; median pvl  5,300,000 copies/ml), 8 RMs with late plateau-phase SIVmac239 infection (PID 533  –
  878; median pvl  660,000 copies/ml), and 12 RMs with controlled SIV infection: 9 infected with SIVmac239(   nef)  (PID  154 – 390;  pvls     
400 copies/ml) and 3 spontaneous controllers of SIVmac239 (PID 105  –  147: pvls      4,000 copies/ml). Differences were assessed by unpaired 
  t   test. (D) The profi  les show the fractional representation of T  EM   cells among proliferating (Ki-67   )  CD4    memory T cells from PLNs from an 
RM 5 d before SIVmac239 infection, at PID 150 (immediately before ART; pvl  4,400,000 copies/ml), and at 4 (pvl  180,000) and 8 d (pvl  
87,000) after ART initiation. (E) The profi  les show the fractional representation of T  EM   cells among proliferating (Ki-67   )  CD4    memory  T 
cells from the blood of an SIVmac239-infected RM at PID 105 (immediately before ART; pvl  3,000,000 copies/ml) and days 4 (pvl  
220,000 copies/ml), 10 (pvl  170,000 copies/ml), and 17 (pvl  24,000 copies/ml) after ART. The arrow indicates the development of a fully 
mature CD4     T EM   cell  population.   